Mirantus Health

Cover Block

Metric	Value
Name	Mirantus Health
Tagline	A health tech startup improving access to specialist eye care through remote diagnostics and tele-ophthalmology.
Headquarters	Berlin, Germany
Founded	2022
Stage	Seed
Business Model	B2B2C
Industry	Healthtech
Technology	Software (Non-AI)
Geography	Western Europe
Growth Profile	Venture Scale
Founding Team	Co-Founders (3+)
Funding Label	Seed (total disclosed ~$5,960,000)

Links

• Website: https://www.mirantus.com/
• LinkedIn: https://de.linkedin.com/company/mirantus-health

What an Investor Needs First

Mirantus Health is building a distributed diagnostics network for eye care, a bet positioned to address a severe and growing shortage of specialist ophthalmologists across Western Europe. The Berlin-based startup, founded in 2022, has secured a €5.5 million seed round to scale its core software platform, mira, which enables opticians and mobile clinics to perform standardized screenings and transmit data for remote review by a partner network of over 400 ophthalmologists [Tech.eu, November 2025]. This model, described as diagnostics-as-a-service, aims to create low-threshold access points in communities and care facilities, triaging patients and potentially reducing long-term system costs by catching conditions earlier [EUTechFuture].

The founding team combines medical and operational expertise, with Dr. Claus Gruber serving as Medical Director and Dominik Pederzani leading strategy and product development [ATLAS, 2026] [EUTechFuture]. Their early traction is measured in footprint, with mira active in over 200 locations in Germany and plans to expand to more than 1,000 sites across the DACH region by 2027 [EUTechFuture]. The company's B2B2C model leverages existing optician infrastructure and statutory health insurance.

Data Accuracy: GREEN -- Core facts (founding, funding, product, traction) corroborated by multiple independent sources including Tech.eu, Startbase, and EUTechFuture.

Taxonomy Snapshot

Axis	Classification
Stage	Seed
Business Model	B2B2C
Industry / Vertical	Healthtech
Technology Type	Software (Non-AI)
Geography	Western Europe
Growth Profile	Venture Scale
Founding Team	Co-Founders (3+)
Funding	Seed (total disclosed ~$5,960,000)

Inside the Company

Mirantus Health GmbH was incorporated in Berlin, Germany, in 2022 [Crunchbase]. The founding team, comprising Dominik Pederzani, Dr. med. Claus Gruber, and Philipp Deutschen, launched the company to address a specific structural gap in the German healthcare system: the shortage of ophthalmologists and the resulting long wait times for specialist eye care [EUTechFuture]. The initial concept focused on bringing diagnostic services directly to underserved settings, starting with nursing homes, before evolving into a broader platform for optician-led screenings.

Key operational milestones have followed a clear geographic and network expansion path. The company first established its core software platform, mira, and began deploying it in partner locations across Germany. By late 2025, the service was active in over 200 locations and had built a network of more than 400 partner ophthalmologists for remote review [EUTechFuture, November 2025]. The recent €5.5 million seed financing round, closed in November 2025, is earmarked to fund a significant scaling push, with a stated goal of expanding to more than 1,000 locations across Germany, Austria, and Switzerland by 2027 [Tech.eu, November 2025].

Data Accuracy: YELLOW -- Core founding and location facts are corroborated by Crunchbase, but detailed historical milestones and entity specifics rely on a single trade publication.

Under the Hood

The core offering is a software platform, not a medical device, designed to create new access points for specialist diagnostics. Mirantus Health's product, named 'mira,' is a system that enables opticians and other non-specialist healthcare partners to perform a standardized suite of eye screenings [EUTechFuture, November 2025]. The platform captures key diagnostic data, including retinal imaging, intraocular pressure measurement, slit-lamp imaging, refraction data, and visual acuity testing, and then digitally transmits the complete dataset to a network of ophthalmologists for remote review [EUTechFuture, November 2025]. The company positions this workflow as a 'diagnostics-as-a-service' model, aiming to flag abnormalities and triage patients to appropriate care within 24 to 48 hours, rather than providing a final medical diagnosis [EUTechFuture, November 2025].

Deployment occurs through two primary channels. The first is integration into existing optician businesses [Mirantus Health, 2026]. The second is through mobile screening units, referred to as 'Augenmobile,' which bring the same diagnostic capability to rural communities and nursing homes [EUTechFuture, November 2025]. This dual-channel approach suggests the underlying software is designed to be hardware-agnostic, working with standard ophthalmic imaging equipment at fixed locations and within custom-configured vehicles.

Data Accuracy: GREEN -- Product features and deployment metrics are consistently reported across multiple independent sources [EUTechFuture, Tech.eu, Startbase].

Market Research

The structural shortage of specialist medical care, particularly in aging populations, is creating a non-discretionary market for distributed diagnostic services that can triage patient flow before a crisis hits.

Mirantus Health's core thesis is built on a specific, cited demographic pressure: around 30% of ophthalmologists in Germany are over 60 years old and nearing retirement [EUTechFuture, November 2025]. This attrition occurs against a backdrop of rising demand for eye care, driven by an aging general population and the increasing prevalence of conditions like diabetic retinopathy and age-related macular degeneration. The resulting supply-demand imbalance manifests as long wait times for specialist appointments, estimated in some German regions at over six months, creating a bottleneck that delays diagnosis and increases long-term treatment costs. The company's model of creating 'low-threshold access points' through opticians and mobile units directly addresses this access gap by moving standardized screening upstream of the specialist consultation.

Metric	Value
Current German Locations (2025)	200 locations
Planned DACH Locations (2027)	1000 locations
Partner Ophthalmologist Network	400 specialists

Data Accuracy: GREEN -- Market driver (aging ophthalmologists) and expansion metrics corroborated by multiple independent reports [EUTechFuture, November 2025] [Tech.eu, November 2025].

Competition and Substitutes

Mirantus Health operates in a competitive space defined by a shortage of specialists, positioning its software platform as a triage and access layer between patients, opticians, and ophthalmologists.

Company	Positioning	Stage / Funding	Notable Differentiator
Mirantus Health	B2B2C platform enabling opticians to perform screenings; data sent to a network of ophthalmologists for remote review.	Seed (~$5.96M)	Integrated network of >400 ophthalmologists; mobile units (Augenmobile) for rural/nursing home outreach.

Data Accuracy: YELLOW -- Competitor data is limited; Mirantus's own positioning and network size are corroborated by a single detailed source.

Opportunity

The prize for Mirantus Health is a fundamental reconfiguration of how specialist eye care is delivered across Western Europe, turning a fragmented, capacity-constrained service into a scalable, data-driven network.

The headline opportunity is for Mirantus to become the dominant platform for ophthalmic diagnostics-as-a-service in the DACH region. This outcome is reachable because the company is not merely selling software to a single stakeholder. Instead, it is building a two-sided network that aggregates demand from hundreds of low-threshold access points (opticians, nursing homes) and matches it with a distributed supply of specialist labor [EUTechFuture, November 2025]. The structural catalyst is a severe and worsening shortage of ophthalmologists, with about 30% of the specialist workforce in Germany over 60 and nearing retirement [EUTechFuture, November 2025].

Data Accuracy: YELLOW -- Core opportunity metrics (location count, ophthalmologist network, expansion plans) are confirmed by a single trade publication. The structural market driver (aging specialist workforce) is also cited there.

Sources

1. [Tech.eu, November 2025] Mirantus Health lands €5.5M to bring faster eye screening to 1,000+ locations | https://tech.eu/2025/11/20/mirantus-health-lands-eur55m-to-bring-faster-eye-screening-to-1000-locations/
2. [EUTechFuture] Mirantus Health: Company Overview, Funding, Leadership and Technology | https://eutechfuture.com/health-tech/mirantus-health-company-overview-funding-leadership-and-technology/
3. [Crunchbase] Mirantus Health - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/mirantus-health
4. [Startbase, November 2025] Mirantus Health raises 5.5 million euros | https://www.startbase.com/news/mirantus-health-sammelt-55-mio-euro-ein
5. [Mirantus Health, 2026] Mirantus, https://www.mirantus.com/
6. [ATLAS, 2026] Dr. Claus Gruber is the CEO of Mirantus Health GmbH | https://www.atlas.de/atlas/companies/company/mirantus-health-gmbh
7. [Clay.earth, 2026] Dominik Pederzani is the Founder & CEO at Mirantus Health | https://clay.earth/people/dominik-pederzani-0c7d
8. [The Org, 2026] Philipp Deutschen is the Head of Business Development at Mirantus Health | https://theorg.com/org/mirantus-health/org-chart/philipp-deutschen
9. [Mirantus Health, 2026] Mirantus Health - Die Eye-Health-Plattform Mira Partnerschaft mit EssilorLuxottica | https://www.mirantus.com/blog/die-eye-health-plattform-mira-und-eine-neuen-partnerschaft-mit-essilorluxottica-sollen-betrieben-neue-perspektiven-als-gesundheitsdienstleister-eroffnen